US Broker Ratings

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Biotech with 89% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a cutting-edge player in the biotechnology sector, is capturing investor attention with its promising potential upside of 89.21%. With a focus..

Embecta Corp. (EMBC) Stock Analysis: Navigating Market Challenges with a 37.97% Upside Potential

Embecta Corp. (NASDAQ: EMBC), a stalwart in the medical instruments and supplies industry, is currently trading at $12.08, reflecting a modest price change of 0.16 (0.01%)...

Arvinas, Inc. (ARVN) Stock Analysis: A Biotech Innovator with Phase 3 Trials on the Horizon

Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company situated in the healthcare sector, specializing in the innovative field of targeted protein degradation. With a market..

AbCellera Biologics Inc. (ABCL): Analyzing a Promising 164% Upside in the Biotech Sector

AbCellera Biologics Inc. (ABCL) stands out in the biotech industry with its innovative approach to antibody-based medicine discovery. Headquartered in Vancouver, Canada, AbCellera operates in the..

Maravai LifeSciences Holdings (MRVI): Navigating a 19% Potential Upside Amidst Challenging Metrics

For investors seeking opportunities within the biotechnology sector, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a mix of potential and challenges. Based in San Diego, California,..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 3,575.80% Revenue Surge and Promising Biotechnology Innovations

Investors with a keen eye on the biotechnology sector should take a closer look at Keros Therapeutics, Inc. (NASDAQ: KROS), a dynamic player in the healthcare..

Immunome, Inc. (IMNM) Stock Analysis: A Promising Biotech Play with 53% Upside Potential

Immunome, Inc. (NASDAQ: IMNM), a biotechnology company specializing in targeted cancer therapies, has been capturing the attention of investors with its robust pipeline and significant upside..

iRadimed Corporation (IRMD) Stock Analysis: Riding High with Strong Revenue Growth and Analyst Confidence

iRadimed Corporation (IRMD), a dynamic player in the healthcare sector specializing in medical devices, has been capturing investor attention with its impressive market performance and solid..

InMode Ltd. (INMD) Stock Analysis: Unveiling Growth Potential Amidst Market Challenges

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured attention with its innovative approach to aesthetic..

CeriBell, Inc. (CBLL) Stock Analysis: A Medical Device Innovator with 31% Revenue Growth and Strong Buy Ratings

CeriBell, Inc. (CBLL) has been making waves in the medical devices industry, focusing on transforming the diagnosis and management of neurological conditions. As a healthcare company..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Star with 23.79% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Cogent Biosciences, Inc. (NASDAQ: COGT) presents a compelling case. The company, headquartered in Waltham, Massachusetts, is at the..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a 170% Upside Potential for Savvy Investors

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, specializes in the cash-pay aesthetic market with its innovative product offerings. Headquartered in Newport Beach,..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Navigating a 117% Revenue Growth in Biotech

Stoke Therapeutics, Inc. (NASDAQ: STOK), a burgeoning player in the biotechnology sector, is capturing investor attention with its impressive 117.20% revenue growth. With a current market..

Butterfly Network, Inc. (BFLY) Investor Outlook: Analyzing Growth Potential in the Medical Devices Sector

Butterfly Network, Inc. (NASDAQ: BFLY) is capturing investor attention with its innovative approach to ultrasound imaging. Nestled in the thriving healthcare sector and focusing on the..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unpacking a Potential 150% Upside in the Biotech Arena

Gyre Therapeutics, Inc. (NASDAQ: GYRE) has recently caught the eye of investors with its promising potential for growth, marked by a compelling 150.35% potential upside. Operating..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unveiling a Potential 181% Upside in the Biotechnology Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) is capturing the attention of investors with its intriguing growth potential in the biotechnology sector. Based in San Francisco, this clinical-stage..

Neuropace, Inc. (NPCE) Stock Analysis: Uncovering an 18.90% Upside Potential Amid Robust Revenue Growth

Neuropace, Inc. (NASDAQ: NPCE) has captured the attention of investors with a compelling 18.90% potential upside, driven by its strong position in the healthcare sector, specifically..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Biotech with Nearly 96% Upside Potential

Investors with an appetite for high-risk, high-reward opportunities in the biotechnology sector might find KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) an intriguing proposition. Based in Cambridge, Massachusetts,..

Xencor, Inc. (XNCR) Stock Analysis: Strong Buy Ratings and 82.85% Potential Upside Capture Investor Attention

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company based in Pasadena, California, is making waves in the biotechnology sector with its innovative approach to engineered monoclonal antibodies...

CureVac N.V. (CVAC) Stock Analysis: A 25.92% Potential Upside Amid Market Volatility

CureVac N.V. (CVAC), a prominent player in the biotechnology sector, has captured investor attention with its innovative mRNA-based technologies. Despite the acquisition by BioNTech SE in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds